Brainstorm Cell (BCLI)

$0.84 -0.33 (-28.21%)
Market Cap 11.51M
Revenue (ttm) 0.00
Net Income (ttm) -11.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.16
Volume 819,600
Avg Vol 1,676,626
Day's Range N/A - N/A
Shares Out 9.84M
Stochastic %K 34%
Beta 0.22
Analysts Strong Sell
Price Target $7.50

Company Profile

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 488 0460
Address:
1325 Avenue of Americas, 28th Floor, New York, United States
Strout100
Strout100 Sep. 19 at 8:22 PM
$BCLI Two ways to play future ALS treatments, stem cells to repair damage and tregs to stop future damage or slow it down dramatically. Bcli should have a clear path for the stem cell part, if they can shake off Chaim BS problem, coya sure looks like a big winner on the slow down, both together maybe a home run, again the thorn in the bush is Chaim, ugh. I have started investing in coya, well run and they have a very good partner, which bcli still does not after over 10 years of Chaim looking for one, ugh, ugh, ugh!!!!
0 · Reply
Knuckles30
Knuckles30 Sep. 18 at 4:53 PM
$BCLI Where has the dip shit been hiding?? all his bullshit about Pitts being the man has not done shit for us
3 · Reply
Dakota1961
Dakota1961 Sep. 18 at 4:42 PM
$BCLI have we been halted
1 · Reply
steven1x
steven1x Sep. 17 at 1:04 AM
$BCLI https://share.google/aimode/tNzyrbsb3VLh5PPPh
1 · Reply
taryagg
taryagg Sep. 16 at 9:17 PM
$BCLI no news is NOT good news.
0 · Reply
mfglola
mfglola Sep. 16 at 8:11 PM
$BCLI Anyone notice the nearly two week steady climb in stock price of mnov? Probably due to expectations with their phase 2 NAFLD readout by end of the month but their ibudilast phase3 results in ALS are due by end of year. In the past, Dr Bedlack has said positive things about it, though I don't think he called it a home run.
0 · Reply
HUMBL4Now
HUMBL4Now Sep. 16 at 4:53 PM
$BCLI f**kkkk this gets old. How can 2026 now almost be over without any progress. Q2 2025 I would’ve said by now we would know exactly what the future of Nurown looks like, but here we are. This shit has to change. This can’t be hypothetical forever. This is one of many story’s, that together explain why the US is losing ground and humans as a species aren’t as well off as we could be.
0 · Reply
Floridaorange
Floridaorange Sep. 15 at 8:05 AM
$LCTX $BCLI $RARE Definitely take a look at NGEN👀 Nasdaq-listed, registrational Phase 3 neurorepair company attempting to restore function years after spinal-cord injury—not merely slow deterioration. NervGen says it has approximately US$61 million, runway through anticipated 1H 2028 topline results and FDA alignment on RESTORE. NervGen’s August 2026 update⁠
0 · Reply
Pipemajors82
Pipemajors82 Sep. 10 at 2:48 PM
$BCLI im a little disappointed that there has been no news from Pitts. As the new day-to-day executive, you think after 6 weeks or so he would layout his vision and his first 100 days for running the company? I would definitely expect something by end of month as 3rd qtr comes to an end.
3 · Reply
Senor_ojos_azules
Senor_ojos_azules Sep. 9 at 8:22 PM
$BCLI Are we halted today?
1 · Reply
Latest News on BCLI
No data available.
Strout100
Strout100 Sep. 19 at 8:22 PM
$BCLI Two ways to play future ALS treatments, stem cells to repair damage and tregs to stop future damage or slow it down dramatically. Bcli should have a clear path for the stem cell part, if they can shake off Chaim BS problem, coya sure looks like a big winner on the slow down, both together maybe a home run, again the thorn in the bush is Chaim, ugh. I have started investing in coya, well run and they have a very good partner, which bcli still does not after over 10 years of Chaim looking for one, ugh, ugh, ugh!!!!
0 · Reply
Knuckles30
Knuckles30 Sep. 18 at 4:53 PM
$BCLI Where has the dip shit been hiding?? all his bullshit about Pitts being the man has not done shit for us
3 · Reply
Dakota1961
Dakota1961 Sep. 18 at 4:42 PM
$BCLI have we been halted
1 · Reply
steven1x
steven1x Sep. 17 at 1:04 AM
$BCLI https://share.google/aimode/tNzyrbsb3VLh5PPPh
1 · Reply
taryagg
taryagg Sep. 16 at 9:17 PM
$BCLI no news is NOT good news.
0 · Reply
mfglola
mfglola Sep. 16 at 8:11 PM
$BCLI Anyone notice the nearly two week steady climb in stock price of mnov? Probably due to expectations with their phase 2 NAFLD readout by end of the month but their ibudilast phase3 results in ALS are due by end of year. In the past, Dr Bedlack has said positive things about it, though I don't think he called it a home run.
0 · Reply
HUMBL4Now
HUMBL4Now Sep. 16 at 4:53 PM
$BCLI f**kkkk this gets old. How can 2026 now almost be over without any progress. Q2 2025 I would’ve said by now we would know exactly what the future of Nurown looks like, but here we are. This shit has to change. This can’t be hypothetical forever. This is one of many story’s, that together explain why the US is losing ground and humans as a species aren’t as well off as we could be.
0 · Reply
Floridaorange
Floridaorange Sep. 15 at 8:05 AM
$LCTX $BCLI $RARE Definitely take a look at NGEN👀 Nasdaq-listed, registrational Phase 3 neurorepair company attempting to restore function years after spinal-cord injury—not merely slow deterioration. NervGen says it has approximately US$61 million, runway through anticipated 1H 2028 topline results and FDA alignment on RESTORE. NervGen’s August 2026 update⁠
0 · Reply
Pipemajors82
Pipemajors82 Sep. 10 at 2:48 PM
$BCLI im a little disappointed that there has been no news from Pitts. As the new day-to-day executive, you think after 6 weeks or so he would layout his vision and his first 100 days for running the company? I would definitely expect something by end of month as 3rd qtr comes to an end.
3 · Reply
Senor_ojos_azules
Senor_ojos_azules Sep. 9 at 8:22 PM
$BCLI Are we halted today?
1 · Reply
whistleblower7
whistleblower7 Sep. 9 at 7:27 PM
$BCLI THEY HAVE TO BE OUT OF MONEY SO SOMETHING HAS TO HAPPEN SOON. WE CAN ONLY HOPE THEY WHERE TELLING US THE TRUTH ABOUT STARTING THE TRAIL AND UPLISTING.HARD TO BELIEVE WE ARE STILL WAITING FOR SOMETHING TO HAPPEN
1 · Reply
thres
thres Sep. 6 at 2:21 PM
$BCLI
0 · Reply
mfglola
mfglola Sep. 3 at 6:15 PM
$BCLI Shah's opinion piece in Biospace. https://www.biospace.com/fda/opinion-capricor-replimune-illustrate-why-fda-must-listen-to-rare-disease-specialists
2 · Reply
ALSCellTherapy
ALSCellTherapy Sep. 2 at 8:18 PM
$BCLI
1 · Reply
afc2881
afc2881 Sep. 2 at 7:39 PM
$BCLI Strout.....🙏🏻🙏🏻🙏🏻
0 · Reply
Strout100
Strout100 Sep. 2 at 5:40 PM
$BCLI What's Pitts game plan, the longer he stays the better the odds, 900000 shares times 10, 9 million, times 20 is 18 million, could it happen? 🤔
0 · Reply
ALSCellTherapy
ALSCellTherapy Sep. 1 at 9:19 PM
$BCLI This thing is ready to fly!
1 · Reply
Pipemajors82
Pipemajors82 Aug. 31 at 7:39 PM
$BCLI well, end of week is 14 months for CP. What the hell is going on? If they were rejecting petition dont you yhink they would have said so already?.
2 · Reply
whistleblower7
whistleblower7 Aug. 28 at 5:43 PM
$BCLI JUST SO EVERYONE KNOWS THE MARKET CAP HAS TO BE 50 MILLION TO BE REINSTATED. HOPEFULLY THAT WILL GET ACCOMPLISHED SOON.
2 · Reply
JTSawyer66
JTSawyer66 Aug. 27 at 4:11 AM
$BCLI I still think someone is acquiring shares. I believe someone picked up a 10,000 share block at an aggregate of $1.16/share. I can’t see someone blowing $16,000 if this is a dead end company.
1 · Reply
Cheesyisi
Cheesyisi Aug. 26 at 7:52 PM
$BCLI
0 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 26 at 5:51 PM
$BCLI Moving higher again!!!
1 · Reply